Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Similar Stocks

Compare
285 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$19.68
$964.41M
-0.11%
5 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.48
$1.01B
-53.31%
7 Buy
2 Hold
0 Sell
Strong Buy
Ardelyx
$4.79
$1.17B
-35.36%
6 Buy
2 Hold
0 Sell
Strong Buy
Spyre Therapeutics
$15.30
$972.25M
2.31
-58.66%
6 Buy
1 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$6.66
$835.39M
-74.66%
15 Buy
4 Hold
1 Sell
Moderate Buy
Pulse Biosciences
$15.94
$989.80M
93.21%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
18.88
0.08
0.43%
GERN
Geron
1.48
-1.62
-52.26%
ARDX
Ardelyx
4.79
-2.55
-34.74%
SYRE
Spyre Therapeutics
15.30
-19.01
-55.41%
NTLA
Intellia Therapeutics
6.66
-18.44
-73.47%
PLSE
Pulse Biosciences
15.94
8.25
107.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis